Massimo Calafiore Sells 9,203 Shares of Orthofix Medical Inc. (NASDAQ:OFIX) Stock

Orthofix Medical Inc. (NASDAQ:OFIX) CEO Massimo Calafiore sold 9,203 shares of the business’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $17.14, for a total transaction of $157,739.42. Following the transaction, the chief executive officer now directly owns 124,151 shares in the company, valued at $2,127,948.14. The trade was a 6.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Massimo Calafiore also recently made the following trade(s):

• On Friday, January 10th, Massimo Calafiore sold 10,078 shares of Orthofix Medical stock. The shares were sold at an average price of $16.83, for a total transaction of $169,612.74.

Orthofix Medical Stock Performance

OFIX stock traded up $0.14 on Tuesday, reaching $17.51. 310,639 shares of the company were exchanged, compared to its average volume of 281,380. Orthofix Medical Inc. has a 12 month low of $12.08 and a 12 month high of $20.73. The stock’s fifty day moving average price is $18.17 and its 200 day moving average price is $16.72. The firm has a market capitalization of $669.13 million, a PE ratio of -5.59 and a beta of 1.10. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11.

Hedge Funds Weigh In On Orthofix Medical

A number of institutional investors and hedge funds have recently bought and sold shares of OFIX. Bank of New York Mellon Corp increased its holdings in Orthofix Medical by 6.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 143,772 shares of the medical device company’s stock valued at $1,906,000 after buying an additional 9,118 shares during the period. Victory Capital Management Inc. bought a new stake in shares of Orthofix Medical in the 2nd quarter worth about $832,000. Arizona State Retirement System bought a new stake in shares of Orthofix Medical in the 2nd quarter worth about $139,000. Quest Partners LLC bought a new stake in shares of Orthofix Medical in the 2nd quarter worth about $64,000. Finally, American Century Companies Inc. grew its holdings in shares of Orthofix Medical by 15.7% in the 2nd quarter. American Century Companies Inc. now owns 54,964 shares of the medical device company’s stock worth $729,000 after purchasing an additional 7,475 shares during the last quarter. Institutional investors own 89.76% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on OFIX shares. Roth Mkm reiterated a “buy” rating and issued a $22.00 target price (up from $20.00) on shares of Orthofix Medical in a research note on Friday, November 8th. Stifel Nicolaus upgraded shares of Orthofix Medical from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $18.00 to $24.00 in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Orthofix Medical has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.